Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0007 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.18 | 0.0007 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |